Vesigen Therapeutics

Vesigen Therapeutics is a biotechnology company dedicated to developing groundbreaking therapeutic products. Their proprietary technology, known as ARMMs (ARRDC1-mediated microvesicles), is capable of delivering a variety of payloads, including RNA (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA), directly into the cytoplasm of target cells, expanding the range of treatable targets.